OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env

Documenti analoghi

• P13-03. Neutralizing antibody to HIV-1 Env from hyperimmune bovine colostrum as a mucosal microbicide strategy for preventing virus transmission
  di: Kramski, M, et al.
  Pubblicazione: (2009)
• OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
  di: Jacobs, B, et al.
  Pubblicazione: (2009)
• Co-Expression of miRNA Targeting the Expression of PERK, but Not PKR, Enhances Cellular Immunity from an HIV-1 Env DNA Vaccine
  di: Wheatley, Adam K., et al.
  Pubblicazione: (2011)
• P09-07. Balancing reversion of CTL and neutralizing antibody escape mutations within HIV-1 Env upon transmission
  di: Peut, V, et al.
  Pubblicazione: (2009)
• OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
  di: Tangy, F, et al.
  Pubblicazione: (2009)